Tenofovir Af + Emtricitabine Suppliers & Bulk Manufacturers
Available Forms: Tablet
Available Strengths: Tenofovir AF 25 mg + Emtricitabine 200 mg
Reference Brands: Descovy(EU & US)
Category: Anti Viral
Tenofovir Alafenamide (TAF) + Emtricitabine, sold as Descovy, is a once-daily HIV-1 treatment and PrEP option. It offers strong viral suppression with improved kidney and bone safety compared to TDF-based regimens. FDA and EMA approved.
Product Description:
Tenofovir Alafenamide (TAF) + Emtricitabine is a modern, once-daily antiretroviral combination used for the treatment and prevention of HIV-1 infection. Marketed under the brand name Descovy, this formulation offers a safer alternative to TDF-based regimens, with improved renal and bone safety. TAF is a prodrug of tenofovir, delivering effective viral suppression at a lower dose. Combined with Emtricitabine, an NRTI, it forms the backbone of several HIV therapies like Biktarvy, Genvoya, and Odefsey. Approved by the FDA and EMA, TAF + Emtricitabine is also used in PrEP to reduce the risk of HIV transmission in high-risk populations.
Tenofovir Af + Emtricitabine — third party manufacturing & bulk supply
Tenofovir Af + Emtricitabine is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:
What to include when you enquire
- Destination market — determines which manufacturers hold the right site-level approvals
- First order quantity and estimated annual volume
- Whether you need a registration dossier or the product is already registered
- Packaging, labelling and language requirements
- Incoterms and required shelf life
Manufacturers of Tenofovir Af + Emtricitabine listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding. Narcotic drugs and controlled substances are supplied strictly against valid import and export permits issued by the competent authorities.
Request a quote for Tenofovir Af + Emtricitabine →The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Frequently Asked Questions
Tenofovir alafenamide + emtricitabine is used for the treatment of HIV-1 infection and for pre-exposure prophylaxis (PrEP) to prevent HIV in high-risk individuals. It helps suppress viral replication and supports long-term HIV management.
It is made from two active ingredients: tenofovir alafenamide (TAF), a nucleotide reverse transcriptase inhibitor, and emtricitabine, a nucleoside reverse transcriptase inhibitor. Together they prevent the virus from multiplying.
The main trade name is Descovy in the USA, EU, and UK.
Descovy is manufactured by Gilead Sciences.
The generic name is tenofovir alafenamide + emtricitabine.
The primary brand name is Descovy.
It is manufactured by Gilead Sciences in the USA and EU, with additional production through authorized global partners.
Related Products
Brincidofovir
Strength:
100 mg, 10 mg/ml
Form: Tablets / Oral suspension
Reference Brands: Tembexa (USA/EU)
View Details
Lenacapavir
Strength:
300 mg, 463.5 mg/1.5 mL
Form: Tablet / Injection
Reference Brands: Yeztugo (USA), Sunlenca (USA)
View Details
Quick Response Guaranteed | Verified Suppliers
